Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-29T05:30:33.088Z Has data issue: false hasContentIssue false
  • English
  • Français

Drug Induced Psychosis

Published online by Cambridge University Press:  02 January 2018

Rob Poole  and
Clare Brabbins
Rob Poole*
Affiliation:
Windsor House, Community Mental Health Resource Centre, Liverpool
Clare Brabbins
Affiliation:
Windsor House, Community Mental Health Resource Centre, Liverpool
*
Dr R. Poole, Windsor House, Community Mental Health Resource Centre, 40, Upper Parliament Street, Liverpool, L8 7LF
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
The British Journal of Psychiatry , Volume 168 , Issue 2 , February 1996 , pp. 135 - 138
Copyright
Copyright © 1996 The Royal College of Psychiatrists 

References

Abraham, H. D. (1983) Visual phenomenology of the LSD flashback. Archives of General Psychiatry, 40, 884–889.Google Scholar
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM–IV). Washington, DC: APA.Google Scholar
Ames, F. (1958) A clinical and metabolic study of acute intoxication with Cannabis sativa and its role in the model psychoses. Journal of Mental Science, 104, 972–999.Google Scholar
Andreason, S., Allebeck, P., Engstrom, A., et al (1987) Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet, ii, 1483–1486.CrossRefGoogle Scholar
Angrist, B. M. & Gershon, S. (1970) The phenomenology of experimentally induced amphetamine psychosis: Preliminary observations. Biological Psychiatry, 2, 95–107.Google ScholarPubMed
Bell, D. S. (1965) Comparison of amphetamine psychosis and schizophrenia. British Journal of Psychiatry, 111, 701–707.Google Scholar
Breakey, W. R., Goodell, H., Lorenz, P. C., et al (1974) Hallucinogenic drugs as precipitants of schizophrenia. Psychological Medicine, 4, 255–261.Google Scholar
Cohen, S. I. & Johnson, K. (1988) Psychosis from alcohol or drug abuse. British Medical Journal, 297, 1270–1271.CrossRefGoogle ScholarPubMed
Connell, P. H. (1958) Amphetamine Psychosis. Institute of Psychiatry Maudsley Monograph No. 5. London: Oxford University Press.Google Scholar
Gawin, F. H. & Kleber, H. D. (1986) Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. Archives of General Psychiatry, 43, 107–113.Google Scholar
Gold, M. S. & Bowers, M. B. (1978) Neurobiological vulnerability to low dose amphetamine psychosis. American Journal of Psychiatry, 135, 1546–1548.Google Scholar
Harding, T. & Knight, F. (1973) Marijuana modified mania. Archives of General Psychiatry, 29, 635–637.Google Scholar
Hassiotis, A. & Taylor, J. (1992) Psychotic illness following ‘Mabi Bark Tea’ consumption. British Journal of Psychiatry, 161, 404–407.Google Scholar
Isbell, C., Gorodetzsky, C., Jasinski, D., et al (1967) Effects of Delta-9-transtetrahydrocannabinol in man. Psychopharmacologia, 11, 691–696.CrossRefGoogle Scholar
Janowsky, D. S., El-Yousef, M. K., Davis, J. M., et al (1973) Provocation of schizophrenic symptoms by intravenous administration of methylphenidate. Archives of General Psychiatry, 28, 185–191.Google Scholar
Knudsen, P. & Vilmar, T. (1984) Cannabis and neuroleptic agents in schizophrenia. Acta Psychiatrica Scandinavica, 69, 162–174.CrossRefGoogle ScholarPubMed
Kotin, J., Post, R. M. & Goodwin, K. (1973) Delta-9-tetrahydrocannabinol in depressed patients. Archives of General Psychiatry, 28, 345–348.Google Scholar
Lowenstein, D. H., Massa, S. M., Rowbotham, M. C., et al (1987) Acute neurological and psychiatric complications associated with cocaine abuse. American Journal of Medicine, 83, 841–846.Google Scholar
Lishman, W. A. (1987) Organic Psychiatry. The Psychological Consequences of Cerebral Disorder. Oxford: Black well Scientific Publications.Google Scholar
Mathers, D. C. & Ghodse, A. H. (1992) Cannabis and psychotic illness. British Journal of Psychiatry, 161, 648–653.Google Scholar
McGuire, P. & Fahy, T. (1991) Chronic paranoid psychosis after misuse of MDMA (ecstasy). British Medical Journal, 302, 697.Google Scholar
McGuire, P., Cope, H. & Fahy, T. A. (1994) Diversity of psychopathology associated with use of 3,4-Methylenedioxymethamphetamine (‘Ecstasy’). British Journal of Psychiatry, 165, 391–395.Google Scholar
Negrete, J. C. (1989) Cannabis and schizophrenia. British Journal of Addiction, 84, 349–351.Google Scholar
Negrete, J. C., Knapp, W. P., Douglas, D. E., et al (1986) Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey. Psychological Medicine, 16, 515–520.Google Scholar
Poole, R. G. & Brabbins, C. J. (1994) Psychopathology and ‘ecstasy’. British Journal of Psychiatry, 165, 837.Google Scholar
Ritchie, J., Dick, D. & Lingham, R. (1994) The Report of the Inquiry into the Care and Treatment of Christopher Clunis. London: HMSO.Google Scholar
Satel, S. L., Southwick, S. M. & Gawin, F. H. (1991) Clinical features of cocaine induced paranoia. American Journal of Psychiatry, 148, 495–498.Google Scholar
Smith, J. & Hucker, S. (1994) Schizophrenia and substance abuse. British Journal of Psychiatry, 165, 13–21.CrossRefGoogle ScholarPubMed
Swanson, J. W., Holzer, C. E., Ganju, V. K., et al (1990) Violence and psychiatric disorder in the community: Evidence from the epidemiologic catchment area surveys. Hospital and Community Psychiatry, 41, 761–770.Google ScholarPubMed
Thornicroft, G. (1990) Cannabis and psychosis. Is there epidemiological evidence for an association? British Journal of Psychiatry, 157, 25–33.Google Scholar
Treffert, D. A. (1978) Marijuana use in schizophrenia: A clear hazard. American Journal of Psychiatry, 135, 1213–1215.Google Scholar
Tunving, K. (1985) Psychiatric effects of cannabis use. Acta Psychiatrica Scandinavica, 72, 209–217.Google Scholar
World Health Organization (1992) The Tenth Revision of the International Classification of Diseases and Related Health Problems (ICD–10). Geneva: WHO.Google Scholar
Wright, J. D. & Pearl, L. (1995) Knowledge and experience of young people regarding drug misuse, 1969–94. British Medical Journal, 310, 20–24.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.